Abemaciclib,Trastuzumab,Fulvestrant
eli lilly,roche,Astrazeneca
[' fulv', 'abema', 'lumina', 'monarche', 'monarcher', 'medsir']
analysis of monarcher trial showed abema plus trastu +/- fulv vs trastu plus chemo in hr+ her2+ abc pts, numerically improved os. luminal subtypes were associated with longer pfs (8.6 vs 5.4 mo,hr0.54) and os (31.7 vs 19.7 mo,hr0.68) compared to non-luminal. #esmo22 
Bring your idea to life??Creating successful IITs & optimal drug development??Medica Scientia Innovation Research????????https://t.co/cciUf0lqpM